Marek Poszepczynski
About Marek Poszepczynski
Venture capital investor (Co-Founder) based in Stockholm, Sweden. Focus areas include Health Care, Wellness, Life Science. Invests at seed stage. Past investments include Biovitrum, Pharmalink AB (name changed to Calliditas in 2017), OT Chemistry AB.
Investment focus
Stages
Sectors
Portfolio
No portfolio companies recorded yet; Marek Poszepczynski reports 3 investments overall.